Anna Long-Ruboyianes, PhD
Co Founder
The Product
AxoTech is creating Salus – a robust, instant multi-diagnostic screening device that will allow users in multiple industries to detect predetermined particles in the human system and/or other chemical components.
By using patented technology licensed from the Navy and using our AI algorithm, Salus provides detection recognition on a microbe level in human fluid samples, whether it’s a virus, bacteria, or human chemical particles, such as AFP, CEA, CA19-9, CA724, etc. for cancer, or cardiac enzyme for heart attack.
Our Mission
AxoTech is using patented technology from the Naval Surface Warfare Lab to create an instant multi-diagnostic screening device. Improving diagnoses is a crucial need in today’s world. By innovating diagnostics, we can improve our way of thinking when it comes to health.
AxoTech wants to improve diagnostic outcomes and taking care of our communities.
Technology: The How
Salus, via an alternative optic method, coupled with AI algorithms, can potentially provide an initial screen multi-diagnostic to over 50 diseases with one sample – allowing users to diagnose with data-driven information. No more guessing! This device will be handheld, portable, and will take little to no experience to operate it. This means that any trained staff can record the data and store it in their system files for their diagnostics needs within minutes.
When Salus is ready for the public, its hardware will be equipped with hundreds of “signatures.” These signatures will be the microbial fingerprints. AxoTech will analyze the samples in the lab and the data captured will be stored into Salus. The process will be repeated for predetermined samples. When Salus is shipped it will include a vast library of these microbial fingerprints ready to diagnose.
Our Partners
Who We Are
Gustavo Cruz, MBA
Co Founder
Anna Long-Ruboyianes, PhD
Co Founder
Gustavo Cruz, MBA
Co Founder